RESUMO
The study of the efficiency and safety of the hepatotropic drug Remaxol in oncological patients with minimal, subclinical manifestations of liver dysfunction in the postoperative period was performed. It is shown that using of Remaxolcontributes to leveling the biochemical liver dysfunction: decrease of the concentration of total bilirubin, a decrease serum activity of lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase. The unwanted effects of Remaxol were not identified.
Assuntos
Fígado/efeitos dos fármacos , Neoplasias/sangue , Recuperação de Função Fisiológica/efeitos dos fármacos , Succinatos/uso terapêutico , Cavidade Abdominal/cirurgia , Idoso , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Feminino , Humanos , L-Lactato Desidrogenase/sangue , Fígado/metabolismo , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Neoplasias/patologia , Neoplasias/cirurgia , Neoplasias/terapia , Período Pós-Operatório , S-Adenosilmetionina/farmacologia , S-Adenosilmetionina/uso terapêutico , Succinatos/farmacologia , Resultado do TratamentoRESUMO
Pain syndrome in 127 patients with primary inguinal hernia operated in surgical hospital and in 159 patients after similar surgery in outpatient setting with active movement postoperative regimen was studied. In the latter group relief of postoperative pain was associated with psychological preparation before and after surgery, surgical methods without tension of tissues, early physical activity of patients in postoperative period from the first hour. Absence of pain syndrome after surgery favors surgical treatment of inguinal hernias in one-day hospital.
